Legros N - Search Results

1

Hormone sensitivity in vitro and in vivo of v-ras-transfected MCF-7 cell derivatives.

Van Roy F, Mareel M, Vleminckx K, Beyaert R, Fiers W, Devleeschouwer N, Muquardt C, Legros N, Bracke M, Leclercq G. Van Roy F, et al. Among authors: legros n. Int J Cancer. 1990 Sep 15;46(3):522-32. doi: 10.1002/ijc.2910460332. Int J Cancer. 1990. PMID: 2203690

2

Estrogen receptor status and estradiol sensitivity of MCF-7 cells in exponential growth phase.

Madeddu L, Legros N, Devleeschouwer N, Bosman C, Piccart MJ, LeClercq G. Madeddu L, et al. Among authors: legros n. Eur J Cancer Clin Oncol. 1988 Mar;24(3):385-90. doi: 10.1016/s0277-5379(98)90007-4. Eur J Cancer Clin Oncol. 1988. PMID: 3383942

3

Estrogen conjugates and serum factors mediating the estrogenic trophic effect on MCF-7 cell growth.

Devleeschouwer N, Legros N, Olea-Serrano N, Paridaens R, Leclercq G. Devleeschouwer N, et al. Among authors: legros n. Cancer Res. 1987 Nov 15;47(22):5883-7. Cancer Res. 1987. PMID: 3664489

4

Accumulation of a non-binding form of estrogen receptor in MCF-7 cells under hydroxytamoxifen treatment.

Leclercq G, Legros N, Piccart MJ. Leclercq G, et al. Among authors: legros n. J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):545-52. doi: 10.1016/0960-0760(92)90381-r. J Steroid Biochem Mol Biol. 1992. PMID: 1562525

5

Growth factor-like activity of phenol red preparations in the MCF-7 breast cancer cell line.

Devleeschouwer N, Body JJ, Legros N, Muquardt C, Donnay I, Wouters P, Leclercq G. Devleeschouwer N, et al. Among authors: legros n. Anticancer Res. 1992 May-Jun;12(3):789-94. Anticancer Res. 1992. PMID: 1622138

6

In vitro studies of canine mammary tumors: influence of 17-beta-estradiol and progesterone on cell kinetics parameters.

Lespagnard L, Kiss R, Danguy A, Legros N, Lenglet G, Devleeschouwer N, Paridaens R. Lespagnard L, et al. Among authors: legros n. Oncology. 1987;44(5):292-301. doi: 10.1159/000226498. Oncology. 1987. PMID: 3670796

7

Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line.

Borras M, Jin L, Bouhoute A, Legros N, Leclercq G. Borras M, et al. Among authors: legros n. Biochem Pharmacol. 1994 Nov 29;48(11):2015-24. doi: 10.1016/0006-2952(94)90500-2. Biochem Pharmacol. 1994. PMID: 7802690

8

Antiestrogenic activity of two 11 beta-estradiol derivatives on MCF-7 breast cancer cells.

Jin L, Borrás M, Lacroix M, Legros N, Leclercq G. Jin L, et al. Among authors: legros n. Steroids. 1995 Aug;60(8):512-8. doi: 10.1016/0039-128x(95)00079-6. Steroids. 1995. PMID: 8539793

9

Tamoxifen-induced estrogen receptor up-regulation in mammary tumor cells is not related to growth inhibition.

Legros N, Jin L, Leclercq G. Legros N, et al. Cancer Chemother Pharmacol. 1997;39(4):380-2. doi: 10.1007/s002800050587. Cancer Chemother Pharmacol. 1997. PMID: 9025781

10

Length increase of the side chain of idoxifene does not improve its antagonistic potency in breast-cancer cell lines.

Jin L, Legros N, Leclercq G, Hardcastle IR, Jarman M. Jin L, et al. Among authors: legros n. Cancer Chemother Pharmacol. 1998;41(4):339-42. doi: 10.1007/s002800050748. Cancer Chemother Pharmacol. 1998. PMID: 9488604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters